4.7 Article

Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy

期刊

CHEMICO-BIOLOGICAL INTERACTIONS
卷 273, 期 -, 页码 56-72

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2017.05.025

关键词

HK-2 cell; Podocyte Renin-angiotensin system; Wnt/beta-catenin pathway; Alisol B 23-acetate; Pachymic acid B

资金

  1. National Natural Science Foundation of China [81673578, 81603271]
  2. Program for the New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0954]
  3. project As a Major New Drug to Create a Major National Science and Technology Special [2014ZX09304307-002]

向作者/读者索取更多资源

Renin-angiotensin system (RAS) plays a key role in the development and progression of chronic kidney disease (CKD). Recent studies have demonstrated activation of Wnt/beta-catenin pathway by RAS in CKD. However, the underlying mechanisms of RAS and Wnt/beta-catenin signaling interaction and their contribution to the pathogenesis of CKD have not been fully elucidated. Present study is designed to investigate the role of RAS/Wnt/beta-catenin axis activation in tubulo-interstitial fibrosis and glomerulosclerosis by the cultured HK-2 and podocytes. HK-2 cells and podocytes are treated by angiotensin II (Ang II). Ang II up-regulates expression of various Wnt mRNA and active beta-catenin protein in HK-2 cells and podocytes in the time- and dose-dependent manners. In addition, Ang II induces injury, oxidative stress and inflammation and impaired Nrf2 activation in HK-2 cells and podocytes. This was accompanied by up-regulations of RAS components as well as Wnt1, activated beta-catenin and its target proteins. RAS/Wnt/beta-catenin axis activation results in epithelial-to-mesenchymal transition in HK-2 cells and injuries podocytes. The effect of Ang II is inhibited by losartan and ICG-001, a Wnt/beta-catenin inhibitor. We further found that treatment with natural products, ergone, alisol B 23-acetate and pachymic acid B inhibit extracellular matrix accumulation in HK-2 cells and attenuated podocyte injury, in part, by inhibiting Ang II induced RAS/Wnt/beta-catenin axis activation. In summary, activation of RAS/Wnt/beta-catenin axis results in podocytes and tubular epithelial cell, injury and up-regulations of oxidative, inflammatory and fibrotic pathways. These adverse effects are ameliorated by ergone, alisol B 23-acetate and pachymic acid B. Therefore, these natural products could be considered as novel Wnt/beta-catenin signaling inhibitors and anti-fibrotic agents. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据